Log in to save to my catalogue

MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical p...

MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical p...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7054210

MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice

About this item

Full title

MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice

Publisher

London: Nature Publishing Group UK

Journal title

Nature reviews. Neurology, 2020-03, Vol.16 (3), p.171-182

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Early evaluation of treatment response and prediction of disease evolution are key issues in the management of people with multiple sclerosis (MS). In the past 20 years, MRI has become the most useful paraclinical tool in both situations and is used clinically to assess the inflammatory component of the disease, particularly the presence and evolut...

Alternative Titles

Full title

MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7054210

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7054210

Other Identifiers

ISSN

1759-4758

E-ISSN

1759-4766

DOI

10.1038/s41582-020-0314-x

How to access this item